| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors. | Song, H; Li, CW ; Labaff, AM; Lim, SO; Li, LY; Kan, SF; Chen, Y; Zhang, K; Lang, J; Xie, X; Wang, Y; Huo, LF; Hsu, SC; Chen, X; Zhao, Y; Hung, MC | Biochemical and biophysical research communications 404(1), 68-73 | | | |
| 2016 | AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation. | Li, CW ; Xia, W; Lim, SO; Hsu, JL; Huo, L; Wu, Y; Li, LY; Lai, CC; Chang, SS; Hsu, YH; Sun, HL; Kim, J; Yamaguchi, H; Lee, DF; Wang, H; Wang, Y; Chou, CK; Hsu, JM; Lai, YJ; LaBaff, AM; Ding, Q; Ko, HW; Tsai, FJ; Tsai, CH; Hortobagyi, GN; Hung, MC | Cancer research 76(6), 1451-1462 | | | |
| 2008 | Ankyrin repeats-containing cofactors interact with ADA3 and modulate its co-activator function. | Li, CW ; Dinh, GK; Zhang, A; Chen, JD | The Biochemical journal 413(2), 349-357 | | | |
| 2011 | APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. | Ding, Q; Chang, CJ; Xie, X; Xia, W; Yang, JY; Wang, SC; Wang, Y; Xia, J; Chen, L; Cai, C; Li, H; Yen, CJ; Kuo, HP; Lee, DF; Lang, J; Huo, L; Cheng, X; Chen, YJ; Li, CW ; Jeng, LB; Hsu, JL; Li, LY; Tan, A; Curley, SA; Ellis, LM; Dubois, RN; Hung, MC | The Journal of clinical investigation 121(11), 4526-4536 | | | |
| 2007 | Characterization of transcriptional regulatory domains of ankyrin repeat cofactor-1. | Zhang, A; Li, CW ; Chen, JD | Biochemical and biophysical research communications 358(4), 1034-1040 | | | |
| 2014 | Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer. | Hsu, YH; Yao, J; Chan, LC; Wu, TJ; Hsu, JL; Fang, YF; Wei, Y; Wu, Y; Huang, WC; Liu, CL; Chang, YC; Wang, MY; Li, CW ; Shen, J; Chen, MK; Sahin, AA; Sood, A; Mills, GB; Yu, D; Hortobagyi, GN; Hung, MC | Cancer research 74(17), 4822-4835 | | | |
| 2016 | Deubiquitination and Stabilization of PD-L1 by CSN5. | Lim, SO; Li, CW ; Xia, W; Cha, JH; Chan, LC; Wu, Y; Chang, SS; Lin, WC; Hsu, JM; Hsu, YH; Kim, T; Chang, WC; Hsu, JL; Yamaguchi, H; Ding, Q; Wang, Y; Yang, Y; Chen, CH; Sahin, AA; Yu, D; Hortobagyi, GN; Hung, MC | Cancer cell 30(6), 925-939 | | | |
| 2019 | Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. | Zhu, Y; Yang, J; Xu, D; Gao, XM; Zhang, Z; Hsu, JL; Li, CW ; Lim, SO; Sheng, YY; Zhang, Y; Li, JH; Luo, Q; Zheng, Y; Zhao, Y; Lu, L; Jia, HL; Hung, MC; Dong, QZ; Qin, LX | Gut 68(9), 1653-1666 | | | |
| 2016 | EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. | Lim, SO; Li, CW ; Xia, W; Lee, HH; Chang, SS; Shen, J; Hsu, JL; Raftery, D; Djukovic, D; Gu, H; Chang, WC; Wang, HL; Chen, ML; Huo, L; Chen, CH; Wu, Y; Sahin, A; Hanash, SM; Hortobagyi, GN; Hung, MC | Cancer research 76(5), 1284-1296 | | | |
| 2012 | Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. | Li, CW ; Xia, W; Huo, L; Lim, SO; Wu, Y; Hsu, JL; Chao, CH; Yamaguchi, H; Yang, NK; Ding, Q; Wang, Y; Lai, YJ; LaBaff, AM; Wu, TJ; Lin, BR; Yang, MH; Hortobagyi, GN; Hung, MC | Cancer research 72(5), 1290-1300 | | | |
| 2016 | GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. | Ko, HW; Lee, HH; Huo, L; Xia, W; Yang, CC; Hsu, JL; Li, LY; Lai, CC; Chan, LC; Cheng, CC; Labaff, AM; Liao, HW; Lim, SO; Li, CW ; Wei, Y; Nie, L; Yamaguchi, H; Hung, MC | Oncotarget 7(35), 57131-57144 | | | |
| 2010 | Human ADA3 regulates RARα transcriptional activity through direct contact between LxxLL motifs and the receptor coactivator pocket. | Li, CW ; Ai, N; Dinh, GK; Welsh, WJ; Chen, JD | Nucleic acids research 38(16), 5291-5303 | | | |
| 2004 | Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators. | Zhang, A; Yeung, PL; Li, CW ; Tsai, SC; Dinh, GK; Wu, X; Li, H; Chen, JD | The Journal of biological chemistry 279(32), 33799-33805 | | | |
| 2019 | IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion | Chan, Li-Chuan; Li, Chia-Wei ; Xia, Weiya; Hsu, Jung-Mao; Lee, Heng-Huan; Cha, Jong-Ho; Wang, Hung-Ling; Yang, Wen-Hao; Yen, Er-Yen; Chang, Wei-Chao; Zha, Zhengyu; Lim, Seung-Oe; Lai, Yun-Ju; Liu, Chunxiao; Liu, Jielin; Dong, Qiongzhu; Yang, Yi; Sun, Linlin; Wei, Yongkun; Nie, Lei; Hsu, Jennifer L.; Li, Hui; Ye, Qinghai; Hassan, Manal M.; Amin, Hesham M.; Kaseb, Ahmed O.; Lin, Xin; Wang, Shao-Chun; Hung, Mien-Chie | Journal of Clinical Investigation 129(8), 3324-3338 | | | |
| 2019 | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | Li, H; Li, CW ; Li, X; Ding, Q; Guo, L; Liu, S; Liu, C; Lai, CC; Hsu, JM; Dong, Q; Xia, W; Hsu, JL; Yamaguchi, H; Du, Y; Lai, YJ; Sun, X; Koller, PB; Ye, Q; Hung, MC | Gastroenterology 156(6), 1849-1861.e13 | | | |
| 2019 | Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer. | Han, Y; Li, CW ; Hsu, JM; Hsu, JL; Chan, LC; Tan, X; He, GJ | American journal of cancer research 9(4), 800-815 | | | |
| 2016 | Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. | Wang, Y; Hsu, JM; Kang, Y; Wei, Y; Lee, PC; Chang, SJ; Hsu, YH; Hsu, JL; Wang, HL; Chang, WC; Li, CW ; Liao, HW; Chang, SS; Xia, W; Ko, HW; Chou, CK; Fleming, JB; Wang, H; Hwang, RF; Chen, Y; Qin, J; Hung, MC | Cancer research 76(23), 7049-7058 | | | |
| 2011 | p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. | Chang, CJ; Chao, CH; Xia, W; Yang, JY; Xiong, Y; Li, CW ; Yu, WH; Rehman, SK; Hsu, JL; Lee, HH; Liu, M; Chen, CT; Yu, D; Hung, MC | Nature cell biology 13(3), 317-323 | | | |
| 2019 | Palmitoylation stabilizes PD-L1 to promote breast tumor growth. | Yang, Y; Hsu, JM; Sun, L; Chan, LC; Li, CW ; Hsu, JL; Wei, Y; Xia, W; Hou, J; Qiu, Y; Hung, MC | Cell research 29(1), 83-86 | | | |
| 2017 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Jiao, S; Xia, W; Yamaguchi, H; Wei, Y; Chen, MK; Hsu, JM; Hsu, JL; Yu, WH; Du, Y; Lee, HH; Li, CW ; Chou, CK; Lim, SO; Chang, SS; Litton, J; Arun, B; Hortobagyi, GN; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 23(14), 3711-3720 | | | |
